Roger Schibli

Q: What Schools Are Affiliated With Roger Schibli

Roger Schibli is affiliated with the following schools: ETH Zurich, University of Missouri, University of Pittsburgh, University of Barcelona, University of Zurich, Vrije Universiteit Brussel

Roger Schibli's AcademicInfluence.com Rankings

Roger Schibli

Computer Science

#10011

World Rank

#10503

Historical Rank

Computational Linguistics

#2502

World Rank

#2527

Historical Rank

Machine Learning

#4532

World Rank

#4583

Historical Rank

Artificial Intelligence

#4891

World Rank

#4955

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Roger Schibli's Degrees

PhD Computer Science ETH Zurich
Masters Computer Science University of Zurich
Bachelors Computer Science University of Zurich

Similar Degrees You Can Earn

Why Is Roger Schibli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roger Schibli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional Ligand (1998) (559)
Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3]+. (2001) (346)
Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. (2000) (309)
Metal chelating systems synthesized using the copper(I) catalyzed azide-alkyne cycloaddition. (2010) (309)
Basic aqueous chemistry of [M(OH2)3(CO)3]+ (M=Re, Tc) directed towards radiopharmaceutical application (1999) (287)
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex (1999) (275)
Current use and future potential of organometallic radiopharmaceuticals (2002) (269)
Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase. (2010) (260)
"Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step. (2006) (254)
Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. (2010) (221)
Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates. (2014) (203)
In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas (2014) (184)
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative (2012) (167)
In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548 (2013) (165)
Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression (2012) (164)
Steps toward high specific activity labeling of biomolecules for therapeutic application: preparation of precursor [(188)Re(H(2)O)(3)(CO)(3)](+) and synthesis of tailor-made bifunctional ligand systems. (2002) (154)
"Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest. (2008) (149)
Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice (2014) (147)
Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. (1999) (138)
DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice (2013) (133)
Folic Acid Conjugates for Nuclear Imaging of Folate Receptor–Positive Cancer (2011) (126)
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617 (2017) (124)
New derivatives of vitamin B12 show preferential targeting of tumors. (2008) (111)
ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo (2016) (109)
The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy. (2010) (108)
Reactions with the technetium and rhenium carbonyl complexes (NEt4)2[MX3(CO)3]. Synthesis and structure of [Tc(CN-But)3(CO)3](NO3) and (NEt4)[Tc2(μ-SCH2CH2OH)3(CO)6] (1996) (106)
"Click-to-chelate": in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue. (2008) (99)
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile. (2018) (95)
Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent β−-Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate (2013) (90)
Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. (2006) (89)
Metal carbonyl syntheses XXII. Low pressure carbonylation of [MOCl4]− and [MO4]−: the technetium(I) and rhenium(I) complexes [NEt4]2[MCl3(CO)3]☆ (1995) (89)
99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent. (1999) (87)
Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core. (2008) (87)
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. (2018) (82)
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer (2019) (82)
Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. (2015) (81)
A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. (2002) (80)
Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against Glut 1 and hexokinase. (2005) (80)
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. (2010) (78)
A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor. (2009) (78)
Derivatization of glucose and 2-deoxyglucose for transition metal complexation: substitution reactions with organometallic 99mTc and Re precursors and fundamental NMR investigations. (2001) (78)
Can animal data predict human outcome? Problems and pitfalls of translational animal research (2012) (78)
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents (2015) (77)
Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate (2014) (77)
Cyclotron production of (44)Sc: From bench to bedside. (2015) (77)
18F‐Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts (2012) (74)
Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. (2008) (73)
SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate (2008) (71)
Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. (2008) (70)
Prospects in Folate Receptor-Targeted Radionuclide Therapy (2013) (69)
Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies (2012) (69)
[18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting. (2012) (67)
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics (2016) (65)
Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting (2006) (64)
Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer (2015) (64)
Folate Receptor Targeted Alpha-Therapy Using Terbium-149 (2014) (61)
Cu(I)-catalyzed intramolecular cyclization of alkynoic acids in aqueous media: a "click side reaction". (2007) (60)
Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography. (2011) (60)
First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands (2019) (56)
Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization (2017) (55)
Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase. (2008) (55)
Enhanced sensitivity to drugs of abuse and palatable foods following maternal overnutrition (2016) (54)
Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice. (2014) (54)
Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor–Positive Ovarian Cancer (2008) (54)
Structural and (99)Tc NMR Investigations of Complexes with fac-[Tc(CO)(3)](+) Moieties and Macrocyclic Thioethers of Various Ring Sizes: Synthesis and X-ray Structure of the Complexes fac-[Tc(9-ane-S(3))(CO)(3)]Br, fac-[Tc(2)(tosylate)(2)(18-ane-S(6))(CO)(6)], and fac-[Tc(2)(20-ane-S(6)-OH)(CO)(6)][ (1998) (54)
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. (2002) (54)
HYDROLYSIS OF THE ORGANOMETALLIC AQUA ION FAC-TRIAQUATRICARBONYLRHENIUM(I). MECHANISM, PKA, AND FORMATION CONSTANTS OF THE POLYNUCLEAR HYDROLYSIS PROD UCTS (1997) (53)
A Click Approach to Structurally Diverse Conjugates Containing a Central Di‐1,2,3‐triazole Metal Chelate (2009) (53)
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations (2016) (53)
Potential of the "[M(CO)3]+" (M = Re, Tc) Moiety for the Labeling of Biomolecules (1997) (53)
Quantification of Brain Glucose Metabolism by 18F-FDG PET with Real-Time Arterial and Image-Derived Input Function in Mice (2013) (53)
Organometallic 99mTc-technetium(I)- and Re-rhenium(I)-folate derivatives for potential use in nuclear medicine (2004) (51)
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model (2014) (51)
Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting. (2013) (50)
The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. (2009) (50)
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy (2009) (50)
47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes (2017) (49)
Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters (2017) (49)
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. (2015) (48)
First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44Sc-DOTATOC: A Proof-of-Concept Study. (2017) (47)
Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor. (2015) (46)
Bis(thiosemicarbazones) as bifunctional chelators for the room temperature 64-copper labeling of peptides. (2010) (46)
Towards Translational ImmunoPET/MR Imaging of Invasive Pulmonary Aspergillosis: The Humanised Monoclonal Antibody JF5 Detects Aspergillus Lung Infections In Vivo (2017) (46)
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. (2014) (45)
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC. (2017) (45)
Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors. (2007) (45)
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy. (2016) (45)
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate (2016) (44)
5-(2-18F-Fluoroethoxy)-l-Tryptophan as a Substrate of System L Transport for Tumor Imaging by PET (2012) (44)
Synthesis, in vitro, and in silico evaluation of organometallic technetium and rhenium thymidine complexes with retained substrate activity toward human thymidine kinase type 1. (2008) (44)
Dual, Site‐Specific Modification of Antibodies by Using Solid‐Phase Immobilized Microbial Transglutaminase (2017) (43)
Synthesis and in vitro/in vivo evaluation of novel 99mTc(CO)3-folates. (2006) (43)
Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates. (2011) (43)
In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core. (1999) (42)
Versatile synthetic approach to new bifunctional chelating agents tailor made for labeling with the fac-[M(CO)(3)](+) core (M = Tc, (99m)Tc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)(3)] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid). (2003) (41)
Ligand exchange reactions starting from [Re(CO)3Br3]2−. Synthesis, characterization and structures of rhenium(I) tricarbonyl complexes with thiourea and thiourea derivatives (1996) (41)
Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties. (2017) (40)
Evaluation of 11C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk (2017) (40)
First organometallic inhibitors for human thymidine kinase: synthesis and in vitro evaluation of rhenium(I)- and technetium(I)-tricarbonyl complexes of thymidine (2003) (40)
Imaging Atherosclerotic Plaque Inflammation via Folate Receptor Targeting Using a Novel 18F-Folate Radiotracer (2014) (40)
PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties. (2011) (39)
Radiolabeling and in vitro /in vivo evaluation of N‐(1‐adamantyl)‐8‐methoxy‐4‐oxo‐1‐phenyl‐1,4‐dihydroquinoline‐3‐carboxamide as a PET probe for imaging cannabinoid type 2 receptor (2013) (38)
Structural Basis for Universal Corrinoid Recognition by the Cobalamin Transport Protein Haptocorrin* (2013) (38)
Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET. (2016) (38)
Targets and probes for non-invasive imaging of β-cells (2016) (37)
Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules. (2014) (37)
Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors. (2013) (37)
L1‐CAM‐targeted antibody therapy and 177Lu‐radioimmunotherapy of disseminated ovarian cancer (2012) (37)
In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer (2006) (37)
(64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. (2016) (37)
Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis (2016) (37)
Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo. (2006) (35)
Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy (2019) (35)
A New 18F-Labeled Folic Acid Derivative with Improved Properties for the PET Imaging of Folate Receptor–Positive Tumors (2010) (35)
High-Resolution SPECT Imaging of Stimuli-Responsive Soft Microrobots. (2019) (35)
Application of technetium and rhenium carbonyl chemistry to nuclear medicine. Preparation of [NEt4]2[TcCl3(CO)3] from [NBu4][TcO4] and structure of [NEt4][Tc2(μ-Cl)3(CO)6]; structures of the model complexes [NEt4][Re2(μ-OEt)2(μ-OAc)(CO)6] and [ReBr({-CH2S(CH2)2Cl}2)(CO)3] (1997) (34)
Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer (2019) (34)
Production and separation of 43Sc for radiopharmaceutical purposes (2017) (34)
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617 (2019) (34)
Single photon emission computed tomography tracer. (2013) (33)
Complete Carbonylation of fac‐[Tc(H2O)3(CO)3]+ under CO Pressure in Aqueous Media: A Single Sample Story! (2000) (33)
Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9. (2013) (33)
Cross sections of proton-induced reactions on 152Gd, 155Gd and 159Tb with emphasis on the production of selected Tb radionuclides (2014) (33)
“2 + 1” Dithiocarbamate–isocyanide chelating systems for linking M(CO)3+ (M = 99mTc, Re) fragment to biomolecules (2004) (33)
Molecular Assembly of Multifunctional 99mTc Radiopharmaceuticals Using “Clickable” Amino Acid Derivatives (2010) (33)
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity (2020) (33)
Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy. (2015) (33)
Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study (2019) (32)
Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner (2015) (32)
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27) (2012) (31)
Identification, characterization and suppression of side-products formed during the synthesis of high dose ⁶⁸Ga-DOTA-TATE. (2013) (30)
A comparison of three 67/68Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator (2014) (30)
Tumor Imaging in Patients with Advanced Tumors Using a New 99mTc-Radiolabeled Vitamin B12 Derivative (2014) (30)
Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice. (2010) (30)
Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering (2015) (30)
Delivery of BMP-2 by two clinically available apatite materials: in vitro and in vivo comparison. (2015) (29)
Strategies for the Development of Novel Tumor Targeting Technetium and Rhenium Radiopharmaceuticals (2007) (29)
Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions. (2016) (29)
Development of novel water-soluble, organometallic compounds for potential use in nuclear medicine: synthesis, characterization, and (1)H and (31)P NMR investigations of the complexes fac-[ReBr(CO)3L] (L=bis(bis(hydroxymethyl)phosphino)ethane, bis(bis(hydroxymethyl)phosphino)benzene). (2001) (29)
DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl (2013) (29)
Preclinical evaluation and test–retest studies of [18F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5) (2014) (28)
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease (2021) (28)
Comparative studies of substitution reactions of rhenium(I) dicarbonyl-nitrosyl and tricarbonyl complexes in aqueous media. (2005) (28)
Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging (2015) (28)
Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland. (2008) (28)
Syntheses and characterization of dicarbonyl-nitrosyl complexes of technetium(I) and rhenium(I) in aqueous media: spectroscopic, structural, and DFT analyses. (2005) (28)
Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors. (2017) (28)
Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast. (2012) (27)
Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging. (2013) (27)
Radiolabeling of rituximab with (188)Re and (99m)Tc using the tricarbonyl technology. (2011) (27)
Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals. (2017) (26)
Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model (2014) (26)
Charge dependent substrate activity of C3' and N3 functionalized, organometallic technetium and rhenium-labeled thymidine derivatives toward human thymidine kinase 1. (2010) (26)
Functionalization of glucose at position C-3 for transition metal coordination: organo-rhenium complexes with carbohydrate skeletons. (2005) (26)
Discovery of a fluorinated 4‐oxo‐quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2 (2016) (26)
Improved PET Imaging of Tumors in Mice Using a Novel 18 F-Folate Conjugate with an Albumin-Binding Entity (2013) (26)
Studies toward the development of new silicon-containing building blocks for the direct (18)F-labeling of peptides. (2013) (25)
Versatile routes to C-2- and C-6-functionalized glucose derivatives of iminodiacetic acid. (2003) (25)
Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18. (2016) (25)
Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)- and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ1-Receptor–Targeted PET Imaging (2019) (24)
Imaging Tumour ATB0,+ Transport Activity by PET with the Cationic Amino Acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine (2014) (24)
The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms (2013) (24)
Steps towards [(C5Me5)TcO3]: Novel synthesis of [(C5Me5)Tc(CO)3] from [{Tc(μ3−OH)(CO)3}4] and oxidation of [(C5Me5)M(CO)3] (M = Tc, Re) with Br2 (1998) (24)
Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor (2018) (24)
A simple single-step synthesis of [99Tc3H3(CO)12] from [99TcO4]– and its X-ray crystal structure. Application to the production of no-carrier added [188Re3H3(CO)12] (1996) (24)
HAX1 deficiency: Impact on lymphopoiesis and B‐cell development (2010) (24)
Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models (2013) (24)
Quantitative positron emission tomography of mGluR5 in rat brain with [18F]PSS232 at minimal invasiveness and reduced model complexity (2015) (24)
First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC (2021) (23)
Microbial Transglutaminase and c‐myc‐Tag: A Strong Couple for the Functionalization of Antibody‐Like Protein Scaffolds from Discovery Platforms (2015) (22)
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys. (2007) (22)
18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study (2019) (22)
Synthesis and biological evaluation of (18)F-labeled Fluoroethoxy tryptophan analogues as potential PET tumor imaging agents. (2014) (22)
Folate Receptor-Targeted Radionuclide Imaging Agents (2011) (21)
Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue. (2018) (21)
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging. (2018) (21)
Investigation of the chick embryo as a potential alternative to the mouse for evaluation of radiopharmaceuticals. (2015) (21)
Synthesis, characterization and X-ray crystal structure of [Re(L4)(CO)3]Br·2CH3OH (L4 = N,N-bis[(2-diphenylphosphino)ethyl]-methoxyethylamine) : A model compound for novel cationic 99mTc(I)-tricarbonyl radiotracers useful for heart imaging (2006) (21)
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC (2020) (21)
On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion. (2020) (21)
Novel peptide probes to assess the tensional state of fibronectin fibers in cancer (2017) (21)
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis. (2017) (21)
Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2 (2018) (21)
Novel Coordination Behavior of fac-[ReBr3(CO)3]2- with 1,3,5-Triaza-7-phosphaadamantane (PTA). Systematic Investigation on Stepwise Replacement of the Halides by PTA Ligand. Phase Transfer Studies and X-ray Crystal Structure of [NEt4][ReBr2((PTA)(CO)3], [ReBr(PTA)2(CO)3], and [Re(PTA)3(CO)3]PF6 (1998) (20)
Targeted 64 Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. (2019) (20)
Structure-Affinity Relationships of 2,3,4,5-Tetrahydro-1H-3-benzazepine and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2,3,4,5-Tetrahydro-1H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-d-aspartate Receptors. (2019) (19)
Radiation dosimetry of 18F-AzaFol: A first in-human use of a folate receptor PET tracer (2020) (19)
Comparison of Recombinant Human Haptocorrin Expressed in Human Embryonic Kidney Cells and Native Haptocorrin (2012) (19)
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging (2016) (19)
Synthesis, in vitro and in silico assessment of organometallic Rhenium(I) and Technetium(I) thymidine complexes (2007) (19)
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population (2020) (19)
Synthesis and structures of technetium(I) and rhenium(I) tricarbonyl complexes with bis(diphenylthiophosphoryl)amide, |M(CO)3[(Ph2PS)2N](CH3CN)| (M = Tc, Re) (1998) (19)
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients (2018) (18)
PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues (2012) (18)
Glycation Methods for Bombesin Analogs Containing the (NαHis)Ac chelator for 99mTc(CO)3 Radiolabeling (2008) (18)
CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers (2017) (18)
Synthesis and Evaluation of Bombesin Analogues Conjugated to Two Different Triazolyl‐Derived Chelators for 99mTc Labeling (2010) (18)
Peptides radiolabeled with Re-186/188 and Tc-99m as potential diagnostic and therapeutic agents (2007) (17)
First Clinical Results of (d)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non–Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma (2014) (17)
Evaluation of 99mTc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis (2018) (17)
Single-step radiofluorination of peptides using continuous flow microreactor. (2012) (17)
Enzymatic antibody modification by bacterial transglutaminase. (2013) (17)
Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides. (1999) (17)
Organometallic [Re(CO)3]+ and [Re(CO)2(NO)]2+ labeled substrates for human thymidine kinase 1. (2009) (17)
Evaluation of ¹¹¹In-Labelled Exendin-4 Derivatives Containing Different Meprin β-Specific Cleavable Linkers (2015) (17)
Synthesis of rhenium(I) and technetium(I) carbonyl/dithioether ligand complexes bearing 3,17β-estradiol (1997) (17)
Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations (2019) (17)
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor (2014) (16)
Synthesis and Pharmacological Evaluation of [11C]Granisetron and [18F]Fluoropalonosetron as PET Probes for 5-HT3 Receptor Imaging. (2016) (15)
Synthesis, Radiolabeling, and Biological Evaluation of 5-Hydroxy-2-[(18)F]fluoroalkyl-tryptophan Analogues as Potential PET Radiotracers for Tumor Imaging. (2016) (15)
Scandium-44 DOTATOC PET/CT: First in-human molecular imaging of neuroendocrine tumors and possible perspectives for Theranostics (2015) (15)
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. (2020) (14)
Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model (2015) (14)
Synthesis of tricarbonyl rhenium and technetium complexes of a 5′-carboxamide 5-ethyl-2′-deoxyuridine for selective inhibition of herpes simplex virus thymidine kinase 1 (2007) (14)
Exendin-4 derivatives with an albumin-binding moiety show decreased renal retention and improved GLP-1 receptor targeting. (2019) (14)
Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions. (2020) (14)
Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer. (2014) (14)
MRS glucose mapping and PET joining forces: re‐evaluation of the lumped constant in the rat brain under isoflurane anaesthesia (2014) (13)
Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model (2014) (13)
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5. (2012) (13)
Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting. (2020) (13)
The A/T/N model applied through imaging biomarkers in a memory clinic (2019) (13)
A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5 (2018) (13)
GABAA receptor subtypes in the mouse brain: Regional mapping and diazepam receptor occupancy by in vivo [18F]flumazenil PET (2017) (13)
Metal Chelating Systems Synthesized Using the Copper(I)‐Catalyzed Azide—Alkyne Cycloaddition (2010) (12)
Methoxinine – an alternative stable amino acid substitute for oxidation‐sensitive methionine in radiolabelled peptide conjugates (2017) (12)
Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging (2021) (12)
FDG kinetic modeling in small rodent brain PET: optimization of data acquisition and analysis (2013) (12)
Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis (2020) (11)
Elucidating the Structure-Activity Relationship of the Pentaglutamic Acid Sequence of Minigastrin with Cholecystokinin Receptor Subtype 2. (2019) (11)
Synthesis and preliminary biological evaluation of O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine ([18F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging (2014) (11)
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain. (2014) (11)
[(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes. (2013) (11)
Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis. (2007) (11)
Brain Glucose Transport and Phosphorylation Under Acute Insulin-Induced Hypoglycemia in Mice: An 18F-FDG PET Study (2013) (11)
Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. (2019) (11)
Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N (2020) (10)
Fluorinated quinazolinones as potential radiotracers for imaging kinesin spindle protein expression. (2013) (10)
Expression of functional folate receptors by human parathyroid cells. (2013) (10)
Diving at diminished atmospheric pressure: air decompression tables for different altitudes. (1976) (10)
Implementation of a new separation method to produce qualitatively improved 64 Cu. (2019) (10)
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms (2021) (10)
Noninvasive PET Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering (2016) (10)
A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice (2017) (10)
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI (2021) (10)
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile (2020) (9)
Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging (2021) (9)
165Er: A new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets. (2020) (9)
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? (2020) (9)
In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET (2020) (9)
First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1 (2021) (9)
Radiosynthesis and evaluation of an 18F–labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma (2018) (8)
Reduced 18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging. (2018) (8)
In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs. (2018) (8)
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma (2018) (8)
Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy (2020) (8)
Development of [(18)F]-PSS223 as a PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGluR5). (2012) (8)
Combined Application of Albumin-Binding [177Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics. (2020) (8)
Recording Intracellular Molecular Events from the Outside: Glycosylphosphatidylinositol-Anchored Avidin as a Reporter Protein for In Vivo Imaging (2011) (8)
In Vitro and In Vivo Characterization of a Novel Bifunctionalized Water-Soluble Dithia-Bisphosphine 99mTc Complex (1998) (8)
Synthesis and In Vitro Evaluation of E- and Z-Geometrical Isomers of PSS232 as Potential Metabotropic Glutamate Receptors Subtype 5 (mGlu5) Binders (2013) (8)
Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers. (2012) (8)
In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research. (2013) (7)
Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes. (2019) (7)
The influence of physical work upon decompression time after simulated oxy-helium dives. (1972) (7)
Physiologically Based Pharmacokinetic Modelling with Dynamic PET Data to Study the In Vivo Effects of Transporter Inhibition on Hepatobiliary Clearance in Mice (2018) (7)
[Measurement of nasal airway resistance: methods and normal values]. (1973) (7)
Radiopharmaceuticals: From molecular imaging to targeted radionuclide therapy (2004) (7)
GABA A receptor subtypes in the mouse brain : Regional mapping and diazepam receptor occupancy by in vivo [ 18 F ] flumazenil PET (2017) (7)
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4 (2019) (7)
Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaques (2015) (7)
Synthesis of a Novel γ-FolicAcid-Nτ-HistidineConjugate Suitable for Labeling with 99mTcand 188Re (2009) (6)
Technetium in Medicine (2007) (6)
Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging. (2015) (6)
Functionalization of glucose for the labeling with 99mTc‐tricarbonyl (2001) (6)
Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations (2021) (6)
Diastereomerically Pure 6R- and 6S-3′-Aza-2′-18F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor–Positive KB Tumors (2018) (6)
Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates (2018) (6)
Injected Human Muscle Precursor Cells Overexpressing PGC-1α Enhance Functional Muscle Regeneration after Trauma (2018) (5)
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy (2020) (5)
Synthesis and Evaluation of Biphenyl Compounds as Kinesin Spindle Protein Inhibitors (2013) (5)
[18F]Flurpiridaz: Facile and Improved Precursor Synthesis for this Next‐Generation Cardiac Positron Emission Tomography Imaging Agent (2020) (5)
Chemoselective 18F-incorporation into pyridyl acyltrifluoroborates for rapid radiolabelling of peptides and proteins at room temperature. (2019) (5)
Radiometal labeling of antibodies and antibody fragments for imaging and therapy. (2004) (5)
Making the step from diagnosis to therapy: Improved 99mTc/188Re‐tricarbonyl preparation for high specific activity labeling of biomolecules (2001) (5)
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model (2020) (5)
1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs. (2021) (5)
[11C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [18F]LMI1195 uptake is NET-independent (2020) (5)
SYNTHESIS AND STRUCTURE AFFINITY RELATIONSHIP OF SMALL MOLECULES FOR IMAGING HUMAN CD80 BY POSITRON EMISSION TOMOGRAPHY. (2019) (5)
Water-exchange study revealed unexpected substitution behavior of [(CO)2(NO)Re(H2O)3]2+ in aqueous media. (2006) (5)
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands (2021) (5)
1 In Vivo Imaging of Prostate Cancer Using [ 68 Ga ]-Labeled Bombesin Analog BAY 86-7548 (2013) (5)
Targeted Radiotherapeutics from 'Bench-to-Bedside'. (2020) (4)
Synthesis of Precursors for (18)F-Labeling of Folic Acid for PET Application (2011) (4)
Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat Brain (2018) (4)
An Overview of Targeted Radiotherapy (2019) (4)
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute (2019) (4)
Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice (2021) (4)
Therapeutic Potential of 47 Sc in Comparison to 177 Lu and 90 Y : Preclinical Investigations (2019) (4)
The Metamorphosis of Radionuclide Production and Development at Paul Scherrer Institute. (2020) (3)
Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria (2019) (3)
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve (2022) (3)
Radiolabeled 111In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo Imaging. (2017) (3)
Transplantation and Tracking of Human Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment and Distribution by Hybrid SPECT-CT Imaging of Sodium Iodide Symporter Trangene Expression (2012) (3)
Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - final Results of the phase 0 'Lumed' Study (2019) (3)
Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N (2021) (3)
Synthesis and Biological Evaluation of Quinoxaline Derivatives for PET Imaging of the NMDA Receptor (2017) (3)
Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques. (2013) (3)
Unexpected reactivity of cyclic perfluorinated iodanes with electrophiles. (2018) (3)
Chapter 3 In vivo anti-tumor activity of the organometallic ruthenium ( II )-arene complex [ Ru ( ɳ 6p-cymene ) Cl 2 ( pta ) ] ( RAPTA-C ) in human ovarian and colorectal carcinomas (2015) (3)
Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities. (2022) (3)
Structural investigations of re‐tricarbonyl labeled neurotensin analogues using 1D and 2D “magic angle spinning” NMR techniques (2001) (3)
Synthesis and Biological Evaluation of Quinoxaline Derivatives for PET Imaging of the NMDA Receptor (2017) (3)
Distance-Dependent Cellular Uptake of Oligoproline-Based Homobivalent Ligands Targeting GPCRs-An Experimental and Computational Analysis. (2020) (3)
The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC (2021) (3)
A33 FOLATE MEDIATED IMAGING OF ACTIVATED MACROPHAGES IN EXPERIMENTAL OSTEOARTHRITIS USING SPECT/CT (2008) (3)
Synthesis and in vitro/in vivo pharmacological evaluation of [11C]-ThioABP, a novel radiotracer for imaging mGluR5 with PET (2013) (3)
Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy (2021) (3)
Development and evaluation of (44)Ti production on high energy protons (2011) (3)
268 DEVELOPMENT OF 44SC PRODUCTION FOR RADIOPHARMACEUTICAL APPLICATIONS (2012) (3)
Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System. (2020) (2)
Abstract P4-21-18: Pre-clinical antitumor activity, tumor localization, and pharmacokinetics of MP0274, an apoptosis inducing, biparatopic HER2-targeting DARPin® (2017) (2)
Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy. (2022) (2)
Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin 177Lu-PP-F11N (2021) (2)
1 Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography (2016) (2)
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends (2022) (2)
of the organometallic ruthenium ( II )-arene complex [ Ru ( h 6p-cymene )-Cl 2 ( pta ) ] ( RAPTA-C ) in human ovarian and colorectal carcinomas † (2014) (2)
Blood coagulation during critical decompression following diving experiments with oxygen-helium. (1973) (2)
Evaluation of 5H‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers (2020) (2)
Additional file 1: of Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis (2016) (2)
Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone (2021) (2)
[Experimental studies on decompression following diving in mountain lakes at reduced air pressure]. (1973) (2)
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [225Ac]Ac-PSMA-617 (2022) (2)
Application of click chemistry to the design of ligand systems and functionalization of biomolecules suitable for radiolabelling with the technetium and rhenium tricarbonyl core; ; IAEA radioisotopes and radiopharmaceuticals series; Technetium-99m radiopharmaceuticals : status and trends (2009) (2)
Synthetic and structural considerations of organometallic compounds of the elements technetium and rhenium for use in radiopharmacy (2003) (2)
Abstract 3029: FAP-mediated tumor accumulation of a T-cell agonistic FAP/4-1BB DARPin drug candidate analyzed by SPECT/CT and quantitative biodistribution (2018) (2)
Radiosynthesis and pre-clinical evaluation of Al18F labeled bombesin antagonist: Promising tracer for prostate cancer imaging (2012) (1)
The CCK-2 receptor agonist Lu-177-PP-F11N for PRRT of medullary thyroid cancer – Recent results of the phase 1 “LUMED” Study (2021) (1)
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging. (2022) (1)
Evaluation of 99 mTc-rhAnnexin V-128 SPECT / CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis (2018) (1)
In Vivo Imaging of Prostate Cancer Using ( 68 Ga)-Labeled (2013) (1)
Production of four terbium-radioisotopes for radiopharmaceutical applications (2012) (1)
Bifunctional Chelation Systems Based on Hydroxymethyl Phosphine-Based Donor Groups (1999) (1)
Erratum: Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering (2015) (1)
Dual MVK cleavable linkers effectively reduce renal retention of 111In-fibronectin-binding peptides. (2022) (1)
Abstract LB-106: Overcoming limitations of current Antibody-Drug Conjugates (ADCs) by a novel linker technology (2019) (1)
Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. (2021) (1)
[Lung biopsy in interstitial pulmonary processes]. (1976) (1)
Cancer esearch or and Stem Cell Biology ivo Imaging of Inflammation-and Tumor-Induced Lymph e Lymphangiogenesis by Immuno – Positron R ission Tomography (2010) (1)
A preliminary comparison of methods for production of 188Re‐C595 antibody for radioimmunotherapy of bladder cancer (2001) (1)
Preclinical application of 47Sc-folate – A pilot study in tumor-bearing mice (2014) (1)
Synthesis and characterization of [99mTc]metomidate as the tricarbonyl-conjugate (2001) (1)
The use of 149Tb and 152Tb in preclinical investigations: an update on its mass separation and subsequent application for imaging and therapy (2016) (1)
Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer (2022) (1)
Design and Development of New Hydroxy Methyl Phosphine Based Bifunctional Chelating Agents (BFCAs) for Use in Radiopharmaceutical Applications (1999) (1)
Synthesis of a Novel g-Folic Acid – N t-Histidine Conjugate Suitable for Labeling with 99 mTc and 188 Re (2009) (1)
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold. (2022) (1)
Radiation dosimetry of [18F]-PSS232—a PET radioligand for imaging mGlu5 receptors in humans (2019) (1)
Studies toward terminal (fluoroalkyl)silanes. Investigation of diethylaminosulfur trifluoride (DAST) in exchange reactions with some terminal (hydroxyalkyl)silanes (2014) (1)
18th European Symposium on Radiopharmacy and Radiopharmaceuticals (2016) (1)
Single Photon Emission Computed Tomography Tracer. (2020) (1)
177Lu-labelled peptidomimetics: novel minigastrin analogues for improved tumour targeting (2019) (1)
Corrigendum concerning “Methoxinine—An alternative stable amino acid substitute for oxidation‐sensitive methionine in radiolabelled peptide conjugates” (2020) (0)
Triazole Based Chelating Systems for the Tc/Re-Tricarbonyl Core (2007) (0)
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents? (2022) (0)
Personalized Health 2020 29 and 30 June 2020 Virtual Only Personalized (2020) (0)
Development and application of first Sc-44-labeled Affibody molecule (2016) (0)
PNS as tridentate ligand system for the synthesis of Tc(I) and Re(I) tricarbonyl complexes (2001) (0)
Terbium radionuclides for theranostics (2021) (0)
Should new Nuclear Reactors be considered as an option to solve Technetium shortage problem (2012) (0)
Abstract 2514: Towards homogenous adcs: A new site-specific antibody conjugation using bacterial transglutaminase (btg-adc) (2014) (0)
Development of novel cannabinoid type 2 receptor tracers for PET imaging (2013) (0)
64Cu-Labeled Folate Radioconjugate for PET Imaging of Folate Receptor-Positive Tumors (2016) (0)
37: 152/161Tb-DOTA-RM6 biodistribution studies in prostate cancer bearing SCID mice and 149Tb sources from CERN-MEDICIS (2014) (0)
Novel peptide probes to assess the tensional state of fibronectin fibers in cancer (2017) (0)
Novel folic acid radioconjugate with an albumin binding entity : Improved anti-tumor efficacy and reduced side effects (2018) (0)
Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers (2022) (0)
Radiopharmaceuticals for Targeted Tumor Diagnosis and Therapy (2000) (0)
Targeting the immune co-stimulatory molecule CD80 for the imaging of vulnerable atherosclerotic plaques by PET (2014) (0)
Novel approaches in the radiopharmacy of 99Tcm and 186/188Re (1997) (0)
Pilot study of a new Tc-99m labeled vitamin B12 derivative for detection of cancer (2010) (0)
Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile (2022) (0)
Radiosynthesis and evaluation of 18F-2'-fluoro-3'-aza folic acid as a potential PET ligand for imaging folate receptor-positive tumors (2012) (0)
Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT) (2022) (0)
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands (2022) (0)
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma (2018) (0)
High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates (2022) (0)
Systematic Coordination of Water-Soluble Monoand Bidentate Phosphine Ligands to the Organometallic Precursor fac-[Rebr3(Co)3]2- (1999) (0)
Imaging , Diagnosis , Prognosis In Vivo Imaging of Prostate Cancer Using [ 68 Ga ]-Labeled Bombesin Analog BAY 86-7548 (2013) (0)
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain. (2022) (0)
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer (2022) (0)
1 2 Animal SPECT imaging with multi-pinhole apertures and fusion with MRI (0)
Microbial Transglutaminase as a Versatile Tool for Site-Specific Protein Modification (2015) (0)
Production of high-specific-activity erbium-169, ytterbium-175 and thulium-167 (2022) (0)
Kidney protection after a high dose of 177Lu-DOTA-Bz-folate (2012) (0)
Age-dependent cardiac remodelling – role of sex hormones (2020) (0)
OP0083 Molecular targeted imaging biomarkers for personalized medicine strategies in systemic sclerosis-related interstitial lung disease (2017) (0)
Promising potential of [Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model (2020) (0)
Title page (2019) (0)
Clinical SPECT radiopharmaceuticals (2016) (0)
Click chemistry for PET and SPECT (2009) (0)
Medically interesting radiolanthanide terbium-161: from production towards clinical application (2019) (0)
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4 (2022) (0)
Translational immunoPET/MR imaging of invasive pulmonary aspergillosis (2019) (0)
Reactivity of the novel organometallic aqua-ion [(CO)2(NO)Re(H2O) 3]2+: Kinetics of H2O substitution and 17O exchange of CO ligands (2005) (0)
FRI0358 99MTC-RHANNEXIN V-128 as a novel early diagnostic marker for interstitial lung disease associated with systemic sclerosis (2017) (0)
Improved Syntheses of the mGlu5 Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling (2018) (0)
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides (2023) (0)
[Effect of a new oral remedy for a cold (HSP 525 A) on flow resistance of the nose]. (1973) (0)
Antibody targeting of epithelial carcinoma-associated fibroblast activation protein blocks cellular proliferation, migration, and invasion. (2010) (0)
270 177LU QUALITY ANALYSIS FOR AN EFFICIENT PREPARATION OF 177LU-LABELED COMPOUNDS (2012) (0)
Improving the quality of Ga radionuclides to achieve high radiolabeling yields (2022) (0)
203: Moving forward in radionuclide development in Switzerland (2014) (0)
Abstract 3386:In vivoimaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography (2010) (0)
Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake (2021) (0)
Cover Picture: Molecular Assembly of Multifunctional 99mTc Radiopharmaceuticals Using “Clickable” Amino Acid Derivatives (ChemMedChem 12/2010) (2010) (0)
Targeted alpha tumour therapy and other oncological solutions (TATTOOS) as part of Paul Scherrer Institute’s IMPACT large facilities project (2022) (0)
44Sc production development from 44Ca for radiopharmaceutical application (2014) (0)
Abstract 5037: DARPins as powerful targeting agents for radioligand therapeutics (2023) (0)
New radiolabeled derivatives of vitamin B12 with abolished transcobalamin II binding reveal selective targeting of tumors (2007) (0)
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications (2022) (0)
Yes we can! First report on folic acid targeted radionuclide tumor therapy (2012) (0)
Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold (2022) (0)
Effects of the antifolate pemetrexed on radiofolate uptake and distribution in FR-positive tumors and kidneys (2007) (0)
In vitro and in vivo evaluation of a novel 67Ga-DOTA-folate in KB-tumor bearing mice (2010) (0)
Pharmacokinetic of a new Tc-99m labeled vitamin B12 derivative with abolished binding to TC: A story of mice and man (2010) (0)
Cu(I)-Catalyzed Intramolecular Cyclization of Alkynoic Acids in Aqueous Media: A “Click Side Reaction”. (2008) (0)
Synthesis and biological evaluation of ((5-hydroxy(2-(3-[18F]fluoropropyl))tryptophan ([18F]5OH-2FPTRP) as a potential PET tumor imaging agent (2014) (0)
Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging (2022) (0)
Signaling Network Response to Alpha-Particle Targeted Therapy with Actinium-225 Labeled Minigastrin Analogue 225Ac-PP-F11N Reveals Radiosensitizing Potential of HDAC Inhibitors. (2023) (0)
Targeting the GLP-1 receptor on pancreatic beta-cells: signaling and radiopharmaceutical applications (2019) (0)
99mTc(CO)3 radiolabeled Re(Arg11)CCMSH for melanoma SPECT imaging (2009) (0)
Targeted Radionuclide Therapy with 161Tb: Investigation of Anti-Tumor Effects and Undesired Side Effects (2016) (0)
Pathogen specific antibody-based molecular imaging of Invasive Aspergillosis with the newly developed PET tracer [64Cu]DOTA-JF5 and its humanized variant [64Cu]NODAGA-hJF5 (2015) (0)
Preclinical study of a novel 99mTc-radiofolate with improved characteristics for folate receptor-positive tumor targeting (2007) (0)
Addendum 3 to the ISOLDE and Neutron Time-of-Flight Committee IS 528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals 11 January 2017 (2017) (0)
[Coronary blood flow during exercise in coronary sclerosis, measured using the precordial xenon-clearance technic]. (1973) (0)
First-in-man evaluation of [18F]-PSS232, a fluorinated PET tracer for mGluR5 (2015) (0)
177 THERANOSTICS OF FOLATE RECEPTOR POSITIVE CANCER USING TERBIUM-RADIOLABELED FOLATE CONJUGATES (2012) (0)
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals. (2023) (0)
F-18 -PSS232-A novel PET radiotracer for imaging of metabotropic glutamate receptors subtype 5 (mGluR5) (2013) (0)
Carbonmonoxidquelle for the production of transition metal carbonyl (2000) (0)
Impact on management of Gallium-68 DOTATATE PET/CT in patients with neuroendocrine tumors (2012) (0)
SUN-334 Evaluation of the CCK-2 Receptor Agonist 177Lu-PP-F11N for PRRT of Medullary Thyroid Carcinoma: Results of a Phase 0 "Lumed" Study (2019) (0)
Aqueous Media: A Single Sample Story!** (2000) (0)
FEMAET: a Cationic Amino Acid PET Probe Targeting the Concentrative Amino Acid Transporter ATB0,+ (2013) (0)
Radiosynthesis, in vitro and in vivo characterization of O-(2- (18)F fluoroethyl)-5-hydroxy-L-tryptophan (2011) (0)
Synthesis and preliminary biological evaluation of O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine ([18F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging (2014) (0)
OP0045 Early Detection of Lung Involvement in Systemic Sclerosis Using Molecular Targeted Imaging (2016) (0)
Front Cover: Evaluation of 5 H ‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers (ChemMedChem 24/2020) (2020) (0)
Crystal Structure of Haptocorrin in Complex with CNCbl (2013) (0)
Title Evaluation of the CCK-2-receptor agonist 177Lu-PP-F11N for peptide receptor radionuclide therapy (PRRT) of medullary thyroid carcinoma - First results of a phase 0 'Lumed' Study (2018) (0)
Radioligand development for imaging cannabinoid receptor subtype 2 with PET (2014) (0)
Optimization and stability studies of thymidine analog complex with organometallic core (2006) (0)
Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roger Schibli?

Roger Schibli is affiliated with the following schools:

Roger Schibli's Academic­Influence.com Rankings

Roger Schibli's Degrees

Similar Degrees You Can Earn

Why Is Roger Schibli Influential?

Roger Schibli's Published Works

Published Works

What Schools Are Affiliated With Roger Schibli?

Roger Schibli's AcademicInfluence.com Rankings